Kurma Partners has closed its fourth biotech venture capital fund after raising 215 million euros ($252 million) to support European…
Read More
European VCs hope to improve the funding landscape for biotechs
Andrew Joseph covers health, medicine, and the biopharma indusattempt in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON…
Read More
Why Silicon Valley is raising billions while San Diego biotechs struggle – San Diego Union-Tribune
Investors are being stingy in San Diego. Cash-poor venture capitalists are consolidating their money into what they believe will yield…
Read More
Why Silicon Valley is raising billions while Southern California biotechs struggle
Investors are being stingy in San Diego. Cash-poor venture capitalists are consolidating their money into what they believe will yield…
Read More
Leen Kawas on Biotech’s Funding Reality Check: How Capital Scarcity is Reshaping R&D Priorities – Finance Monthly
After hitting record highs of $39 billion in venture funding in 2021, the U.S. biotech indusattempt experienced a dramatic reversal.…
Read More
